517
Participants
Start Date
October 23, 2015
Primary Completion Date
April 3, 2017
Study Completion Date
April 3, 2017
Alirocumab
Solution for injection, one subcutaneous injection in the abdomen, thigh, or outer area of upper arm with a disposable auto-injector.
Placebo
Solution for injection, one subcutaneous injection in the abdomen, thigh, or outer area of upper arm with a disposable auto-injector.
Lipid-Modifying Therapy (LMT)
Statins at stable, maximally tolerated dose with or without other LMT as clinically indicated.
Antihyperglycemic Drug
Insulin (injectable or inhaled) alone or with other antihyperglycemic drugs as clinically indicated.
Investigational Site Number 040001, Vienna
Investigational Site Number 056002, Edegem
Investigational Site Number 056001, Leuven
Investigational Site Number 040005, Linz
Investigational Site Number 756001, Olten
Investigational Site Number 040003, Salzburg
Investigational Site Number 040004, Salzburg
Investigational Site Number 040002, Innsbruck
Investigational Site Number 056003, Haine-Saint-Paul
Investigational Site Number 756003, Sankt Gallen
Investigational Site Number 380005, Moncalieri
Investigational Site Number 276002, Berlin
Investigational Site Number 840012, Jamaica
Investigational Site Number 724006, Ferrol
Investigational Site Number 250-004, La Rochelle
Investigational Site Number 724013, Granada
Investigational Site Number 380006, Milan
Investigational Site Number 380007, Milan
Investigational Site Number 276021, Hamburg
Investigational Site Number 840013, Hyattsville
Investigational Site Number 840016, Rockville
Investigational Site Number 276013, Lüneburg
Investigational Site Number 276018, Hamburg
Investigational Site Number 380011, Como
Investigational Site Number 276008, Neumünster
Investigational Site Number 250-008, Besançon
Investigational Site Number 276004, Oldenburg
Investigational Site Number 724005, Madrid
Investigational Site Number 724011, Majadahonda
Investigational Site Number 724008, Málaga
Investigational Site Number 840009, Greer
Investigational Site Number 840021, Roswell
Investigational Site Number 724002, Pamplona
Investigational Site Number 250-001, Toulouse
Investigational Site Number 840023, Jacksonville
Investigational Site Number 724014, Oviedo
Investigational Site Number 840006, Bradenton
Investigational Site Number 840026, Atlantis
Investigational Site Number 840028, Palm Harbor
Investigational Site Number 380012, Verona
Investigational Site Number 840024, Chattanooga
Investigational Site Number 276022, Magdeburg
Investigational Site Number 724003, Seville
Investigational Site Number 840014, Maumee
Investigational Site Number 250-002, Nantes
Investigational Site Number 276011, Dortmund
Investigational Site Number 840011, Indianapolis
Investigational Site Number 840015, Valparaiso
Investigational Site Number 840010, Des Moines
Investigational Site Number 840004, Minneapolis
Investigational Site Number 380001, Pisa
Investigational Site Number 276017, Neuwied
Investigational Site Number 840007, Springfield
Investigational Site Number 276015, Aschaffenburg
Investigational Site Number 276010, Saarlouis
Investigational Site Number 250-006, Strasbourg
Investigational Site Number 276005, Heidelberg
Investigational Site Number 250-003, Le Creusot
Investigational Site Number 250-007, Paris
Investigational Site Number 840003, Dallas
Investigational Site Number 840019, Dallas
Investigational Site Number 840025, Houston
Investigational Site Number 840001, Austin
Investigational Site Number 380009, Napoli
Investigational Site Number 840027, Loveland
Investigational Site Number 840008, Salt Lake City
Investigational Site Number 840017, Ogden
Investigational Site Number 380002, Palermo
Investigational Site Number 250-005, Corbeil-Essonnes
Investigational Site Number 840020, Encino
Investigational Site Number 276016, Sulzbach-Rosenberg
Investigational Site Number 840002, Fresno
Investigational Site Number 840029, Oakland
Investigational Site Number 380004, Catania
Investigational Site Number 840022, Ponte Vedra Beach
Investigational Site Number 840005, Louisville
Investigational Site Number 250-009, Mulhouse
Investigational Site Number 380003, Catanzaro
Investigational Site Number 380008, Padua
Investigational Site Number 528005, Groningen
Investigational Site Number 528004, Utrecht
Investigational Site Number 724004, Madrid
Investigational Site Number 724012, Segovia
Investigational Site Number 840018, Auburn
Investigational Site Number 276019, Dresden
Investigational Site Number 276014, Dresden
Investigational Site Number 276009, Dresden
Investigational Site Number 276003, Pirna
Investigational Site Number 276006, Riesa
Investigational Site Number 380010, Roma
Investigational Site Number 528002, Apeldoorn
Investigational Site Number 528003, Hoogeveen
Investigational Site Number 528001, Rotterdam
Investigational Site Number 724007, Badalona
Investigational Site Number 724001, Barcelona
Investigational Site Number 724009, Palma de Mallorca
Investigational Site Number 724010, Sant Joan Despí
Investigational Site Number 826010, Airdrie
Investigational Site Number 826011, Bath
Investigational Site Number 826009, Bournemouth
Investigational Site Number 826005, Bradford
Investigational Site Number 826004, Bristol
Investigational Site Number 826001, Burton-on-Trent
Investigational Site Number 826015, Durham
Investigational Site Number 826012, High Wycombe
Investigational Site Number 826007, Manchester
Investigational Site Number 826006, Peterborough
Investigational Site Number 826003, Southampton
Investigational Site Number 826008, Truro
Investigational Site Number 826002, Welwyn Garden City
Lead Sponsor
Regeneron Pharmaceuticals
INDUSTRY
Sanofi
INDUSTRY